


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 9 Nov 2007
Planet Technologies Announces Completion of Antigen Laboratories Acquisition
Planet Technologies Announces Completion of Antigen Laboratories Acquisition
HSMN NewsFeed - 8 Nov 2007
FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
HSMN NewsFeed - 8 Nov 2007
InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
HSMN NewsFeed - 8 Nov 2007
Ortho Biotech to Submit Official Request for Reconsideration to CMS Regarding ESA Coverage Policy
Ortho Biotech to Submit Official Request for Reconsideration to CMS Regarding ESA Coverage Policy
HSMN NewsFeed - 8 Nov 2007
Jennerex Appoints Bob Ingram Special Advisor and Hires Marty Glick as EVP, Corporate Strategy
Jennerex Appoints Bob Ingram Special Advisor and Hires Marty Glick as EVP, Corporate Strategy
HSMN NewsFeed - 8 Nov 2007
Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case
Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case
HSMN NewsFeed - 8 Nov 2007
Biopure Submits Complete Response to U.K. Regulatory Body on Marketing Application for Hemopure(R)
Biopure Submits Complete Response to U.K. Regulatory Body on Marketing Application for Hemopure(R)
HSMN NewsFeed - 8 Nov 2007
Neurochem announces important initiatives to provide medical and health benefits to patients
Neurochem announces important initiatives to provide medical and health benefits to patients
HSMN NewsFeed - 8 Nov 2007
Cell Therapeutics, Inc. (CTI) Appoints Jim Fong as Vice President, Commercial Operations
Cell Therapeutics, Inc. (CTI) Appoints Jim Fong as Vice President, Commercial Operations
HSMN NewsFeed - 7 Nov 2007
Fresenius Medical Care Announces: Continued Positive Data from CARE-2 Database
Fresenius Medical Care Announces: Continued Positive Data from CARE-2 Database
HSMN NewsFeed - 7 Nov 2007
BRIGHT Results Show Less Pain and Higher Patient Satisfaction with Betaseron(R) than with Rebif(R)
BRIGHT Results Show Less Pain and Higher Patient Satisfaction with Betaseron(R) than with Rebif(R)
HSMN NewsFeed - 7 Nov 2007
New Clinical Study Shows Limbrel(TM) as Effective as Naproxen for Knee Osteoarthritis
New Clinical Study Shows Limbrel(TM) as Effective as Naproxen for Knee Osteoarthritis
HSMN NewsFeed - 6 Nov 2007
REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide
REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide
HSMN NewsFeed - 6 Nov 2007
Transdel Pharmaceuticals Appoints Mr. Anthony S. Thornley to Its Board of Directors
Transdel Pharmaceuticals Appoints Mr. Anthony S. Thornley to Its Board of Directors
HSMN NewsFeed - 6 Nov 2007
Sloning BioTechnology GmbH Raised EUR 4.7m in a First Closing of a Series E Equity Financing Round
Sloning BioTechnology GmbH Raised EUR 4.7m in a First Closing of a Series E Equity Financing Round
HSMN NewsFeed - 6 Nov 2007
Shire Announces Results of FOSRENOL(R) Study in Pre-Dialysis CKD Stage 3 & 4 Patients
Shire Announces Results of FOSRENOL(R) Study in Pre-Dialysis CKD Stage 3 & 4 Patients
HSMN NewsFeed - 5 Nov 2007
Cleveland Clinic Study Suggests Failure of HDL-Raising Drug Torcetrapib is Likely Compound Specific
Cleveland Clinic Study Suggests Failure of HDL-Raising Drug Torcetrapib is Likely Compound Specific
HSMN NewsFeed - 5 Nov 2007
Synosia Therapeutics Announces Appointment of Vice President of Clinical Research and Development
Synosia Therapeutics Announces Appointment of Vice President of Clinical Research and Development
HSMN NewsFeed - 4 Nov 2007
New Data Presented on GARDASIL(R), Merck's Cervical Cancer Vaccine, in Women Through Age 45
New Data Presented on GARDASIL(R), Merck's Cervical Cancer Vaccine, in Women Through Age 45
HSMN NewsFeed - 1 Nov 2007
Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
HSMN NewsFeed - 1 Nov 2007
Generex Biotechnology Receives Regulatory Approval to Sell Generex Oral-lyn in India
Generex Biotechnology Receives Regulatory Approval to Sell Generex Oral-lyn in India
HSMN NewsFeed - 1 Nov 2007
AVI BioPharma Receives Orphan Drug Designation for AVI-4658 for Treatment of Duchenne Muscular Dystrophy
AVI BioPharma Receives Orphan Drug Designation for AVI-4658 for Treatment of Duchenne Muscular Dystrophy
HSMN NewsFeed - 1 Nov 2007
Triumph-1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint
Triumph-1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint
HSMN NewsFeed - 31 Oct 2007
Duska Therapeutics Appoints Dr. Alan J. Tuchman to the Board of Directors
Duska Therapeutics Appoints Dr. Alan J. Tuchman to the Board of Directors
HSMN NewsFeed - 31 Oct 2007
By 2012, Prescribing Pharmacists Could Influence $145 Billion in Drug Sales
By 2012, Prescribing Pharmacists Could Influence $145 Billion in Drug Sales
HSMN NewsFeed - 31 Oct 2007
Dyax Announces the Appointment of William Pullman as Executive Vice President and Chief Development Officer
Dyax Announces the Appointment of William Pullman as Executive Vice President and Chief Development Officer
HSMN NewsFeed - 31 Oct 2007
Polyanalgesic Consensus Panel's New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain
Polyanalgesic Consensus Panel's New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain
HSMN NewsFeed - 31 Oct 2007
Javelin Pharmaceuticals Receives Marketing Authorization Approval for Dyloject(R) in the United Kingdom
Javelin Pharmaceuticals Receives Marketing Authorization Approval for Dyloject(R) in the United Kingdom
HSMN NewsFeed - 31 Oct 2007
GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial
GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial
HSMN NewsFeed - 30 Oct 2007
New Therapies Emerging to Challenge Pain Management for Transdermal Patch Growth
New Therapies Emerging to Challenge Pain Management for Transdermal Patch Growth
HSMN NewsFeed - 30 Oct 2007
Sciele Pharma and Addrenex Announce Initiation of Pivotal Phase III Trials for Clonicel for ADHD
Sciele Pharma and Addrenex Announce Initiation of Pivotal Phase III Trials for Clonicel for ADHD
HSMN NewsFeed - 30 Oct 2007
Mylan Announces Appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel
Mylan Announces Appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel
HSMN NewsFeed - 30 Oct 2007
NPS Pharmaceuticals Names Douglas N. Dobak Vice President of Regulatory Affairs and Drug Safety
NPS Pharmaceuticals Names Douglas N. Dobak Vice President of Regulatory Affairs and Drug Safety
HSMN NewsFeed - 30 Oct 2007
OncoMed Appoints William D. Waddill Senior Vice President and Chief Financial Officer
OncoMed Appoints William D. Waddill Senior Vice President and Chief Financial Officer
HSMN NewsFeed - 30 Oct 2007
Nexavar Becomes First and Only Approved Treatment of Hepatocellular Carcinoma in Europe
Nexavar Becomes First and Only Approved Treatment of Hepatocellular Carcinoma in Europe
HSMN NewsFeed - 30 Oct 2007
Bradley Pharmaceuticals Announces Definitive Merger Agreement with Nycomed for $20 Per Share in Cash
Bradley Pharmaceuticals Announces Definitive Merger Agreement with Nycomed for $20 Per Share in Cash
HSMN NewsFeed - 30 Oct 2007
Taisho and Pfizer Sign a Letter of Intent for Taisho's Schizophrenia Drug Candidate
Taisho and Pfizer Sign a Letter of Intent for Taisho's Schizophrenia Drug Candidate
HSMN NewsFeed - 29 Oct 2007
Depomed and King Pharmaceuticals Terminate Promotion Agreement for GLUMETZA(TM)
Depomed and King Pharmaceuticals Terminate Promotion Agreement for GLUMETZA(TM)
HSMN NewsFeed - 29 Oct 2007
MGI PHARMA and HELSINN Announce Submission of Supplemental New Drug Application for Aloxi(R) Capsules
MGI PHARMA and HELSINN Announce Submission of Supplemental New Drug Application for Aloxi(R) Capsules
HSMN NewsFeed - 29 Oct 2007
Relypsa Formed With $33 Million Series A Funding to Discover and Develop Polymeric Drugs
Relypsa Formed With $33 Million Series A Funding to Discover and Develop Polymeric Drugs
HSMN NewsFeed - 29 Oct 2007
Sequoia Pharmaceuticals Announces Appointment of Steven D. Skolsky as Chief Executive Officer
Sequoia Pharmaceuticals Announces Appointment of Steven D. Skolsky as Chief Executive Officer
HSMN NewsFeed - 29 Oct 2007
European Symposium Focuses on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management
European Symposium Focuses on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management
HSMN NewsFeed - 29 Oct 2007
Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
HSMN NewsFeed - 29 Oct 2007
ChemGenex Announces Strategic Restructuring of Company to Focus on Late-Stage Cancer Portfolio
ChemGenex Announces Strategic Restructuring of Company to Focus on Late-Stage Cancer Portfolio
HSMN NewsFeed - 29 Oct 2007
Thallion Provides Update on Shigamabs(R) Clinical Development and U.S. Regulatory Plan
Thallion Provides Update on Shigamabs(R) Clinical Development and U.S. Regulatory Plan
HSMN NewsFeed - 29 Oct 2007
DUSA and River's Edge Announce Settlement Agreement Involving Nicomide(R)
DUSA and River's Edge Announce Settlement Agreement Involving Nicomide(R)
HSMN NewsFeed - 29 Oct 2007
Adams Respiratory Therapeutics Receives Approvable Letter From FDA for Mucinex(R) With Codeine
Adams Respiratory Therapeutics Receives Approvable Letter From FDA for Mucinex(R) With Codeine
HSMN NewsFeed - 26 Oct 2007
Genta Announces Resignation of Dr. Betsy McCaughey from Board of Directors
Genta Announces Resignation of Dr. Betsy McCaughey from Board of Directors
HSMN NewsFeed - 25 Oct 2007
Momenta Pharmaceuticals Announces Appointment of Jo-Ann Beltramello as Vice President, Human Resources
Momenta Pharmaceuticals Announces Appointment of Jo-Ann Beltramello as Vice President, Human Resources
HSMN NewsFeed - 25 Oct 2007
BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
HSMN NewsFeed - 25 Oct 2007
KV Pharmaceutical Announces FDA Approval for Morphine ER 100 mg and 200 mg Tablets
KV Pharmaceutical Announces FDA Approval for Morphine ER 100 mg and 200 mg Tablets
HSMN NewsFeed - 25 Oct 2007
VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
HSMN NewsFeed - 25 Oct 2007
Elixir Pharmaceuticals Names Paul M. Martha, M.D. as Chief Medical Officer
Elixir Pharmaceuticals Names Paul M. Martha, M.D. as Chief Medical Officer
HSMN NewsFeed - 25 Oct 2007
Sirion Therapeutics Announces Positive Phase III Results for Difluprednate
Sirion Therapeutics Announces Positive Phase III Results for Difluprednate
HSMN NewsFeed - 25 Oct 2007
Orexo Signs Distribution Agreement with Hospira in Asia for Pain Product Rapinyl(TM)
Orexo Signs Distribution Agreement with Hospira in Asia for Pain Product Rapinyl(TM)
HSMN NewsFeed - 24 Oct 2007
Encysive Pharmaceuticals Announces Long-Term Study of Sitaxsentan Presented At Chest Meeting
Encysive Pharmaceuticals Announces Long-Term Study of Sitaxsentan Presented At Chest Meeting
HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
HSMN NewsFeed - 24 Oct 2007
Eisai Holds Dedication Ceremony to Commemorate New U.S. Corporate Headquarters in Woodcliff Lake, NJ
Eisai Holds Dedication Ceremony to Commemorate New U.S. Corporate Headquarters in Woodcliff Lake, NJ
HSMN NewsFeed - 24 Oct 2007
Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Applied Biology
Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Applied Biology
HSMN NewsFeed - 24 Oct 2007
R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection
R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection
HSMN NewsFeed - 24 Oct 2007
Sucampo Pharmaceuticals Announces CFO Transition in 2008; Elects New Independent Director
Sucampo Pharmaceuticals Announces CFO Transition in 2008; Elects New Independent Director
HSMN NewsFeed - 23 Oct 2007
FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic Acid Capsules
FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic Acid Capsules
HSMN NewsFeed - 23 Oct 2007
BioTime Names Robert W. Peabody Senior Vice President and Chief Operating Officer
BioTime Names Robert W. Peabody Senior Vice President and Chief Operating Officer
HSMN NewsFeed - 23 Oct 2007
Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
HSMN NewsFeed - 22 Oct 2007
European Symposium on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management
European Symposium on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management
HSMN NewsFeed - 22 Oct 2007
AVANT Immunotherapeutics, Inc. and Celldex Therapeutics, Inc. Announce Merger Agreement
AVANT Immunotherapeutics, Inc. and Celldex Therapeutics, Inc. Announce Merger Agreement
HSMN NewsFeed - 22 Oct 2007
Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache
Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache
HSMN NewsFeed - 19 Oct 2007
Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
HSMN NewsFeed - 19 Oct 2007
TransMolecular, Inc. Names Morphotek Executive Nicholas C. Nicolaides, Ph.D., Chairman of the Board
TransMolecular, Inc. Names Morphotek Executive Nicholas C. Nicolaides, Ph.D., Chairman of the Board
HSMN NewsFeed - 19 Oct 2007
Hospira's Biosimilar Epoetin Retacrit(TM) Receives Positive Opinion Recommending EU Approval
Hospira's Biosimilar Epoetin Retacrit(TM) Receives Positive Opinion Recommending EU Approval
HSMN NewsFeed - 18 Oct 2007
Caroline Dorsa to Join Gilead as Senior Vice President and Chief Financial Officer
Caroline Dorsa to Join Gilead as Senior Vice President and Chief Financial Officer
HSMN NewsFeed - 18 Oct 2007
Duska Therapeutics Appoints Shepard Goldberg and Steven Dinh as Board Directors
Duska Therapeutics Appoints Shepard Goldberg and Steven Dinh as Board Directors
HSMN NewsFeed - 17 Oct 2007
FDA Approves Supplemental New Drug Applications for JANUVIA(TM) (sitagliptin)
FDA Approves Supplemental New Drug Applications for JANUVIA(TM) (sitagliptin)
HSMN NewsFeed - 17 Oct 2007
Phenomix Hires John Crawford as Chief Financial Officer and Appoints Arlene Morris to Board of Directors
Phenomix Hires John Crawford as Chief Financial Officer and Appoints Arlene Morris to Board of Directors
HSMN NewsFeed - 17 Oct 2007
Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
HSMN NewsFeed - 17 Oct 2007
OREXIGEN(TM) Therapeutics Initiates its Third Phase III Trial for Contrave(TM) to Treat Obesity
OREXIGEN(TM) Therapeutics Initiates its Third Phase III Trial for Contrave(TM) to Treat Obesity
HSMN NewsFeed - 16 Oct 2007
Cubist Pharmaceuticals Announces Exclusive Option to Acquire Illumigen Biosciences
Cubist Pharmaceuticals Announces Exclusive Option to Acquire Illumigen Biosciences
HSMN NewsFeed - 16 Oct 2007
ViRexx Announces Second OvaRex(R) MAb Phase III Trial Reaches 118th Relapse Event
ViRexx Announces Second OvaRex(R) MAb Phase III Trial Reaches 118th Relapse Event
HSMN NewsFeed - 16 Oct 2007
Savient Pharmaceuticals Completes Puricase(R) Phase 3 Studies for Treatment-Failure Gout
Savient Pharmaceuticals Completes Puricase(R) Phase 3 Studies for Treatment-Failure Gout
HSMN NewsFeed - 16 Oct 2007
Cortex Names Pierre V. Tran, MD, MMM, Chief Medical Officer and Vice President of Clinical Development
Cortex Names Pierre V. Tran, MD, MMM, Chief Medical Officer and Vice President of Clinical Development
HSMN NewsFeed - 16 Oct 2007
Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
HSMN NewsFeed - 16 Oct 2007
Biovest Announces Strategy for Seeking Early Approval of Its Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
Biovest Announces Strategy for Seeking Early Approval of Its Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
HSMN NewsFeed - 16 Oct 2007
Metastatix Appoints Carol G. Gallagher, Pharm.D. as President and Chief Executive Officer
Metastatix Appoints Carol G. Gallagher, Pharm.D. as President and Chief Executive Officer
HSMN NewsFeed - 15 Oct 2007
OSI Pharmaceuticals Provides Additional Information about US Sales of Tarceva
OSI Pharmaceuticals Provides Additional Information about US Sales of Tarceva
HSMN NewsFeed - 15 Oct 2007
Dong-A PharmTech Signs Licensing Deal With Otechestvennye to Market Zydena in Russia
Dong-A PharmTech Signs Licensing Deal With Otechestvennye to Market Zydena in Russia
HSMN NewsFeed - 15 Oct 2007
Velcura Therapeutics, Inc. Appoints Industry Executive to Lead Regulatory Affairs
Velcura Therapeutics, Inc. Appoints Industry Executive to Lead Regulatory Affairs
HSMN NewsFeed - 15 Oct 2007
Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS
Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS
HSMN NewsFeed - 15 Oct 2007
Ligand Earns Milestone Payment as Wyeth Submits European Market Authorization for Bazedoxifene
Ligand Earns Milestone Payment as Wyeth Submits European Market Authorization for Bazedoxifene
HSMN NewsFeed - 15 Oct 2007
Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077
Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077
HSMN NewsFeed - 15 Oct 2007
FDA Expands VELCADE(R) (Bortezomib) for Injection Label for Patients with Multiple Myeloma
FDA Expands VELCADE(R) (Bortezomib) for Injection Label for Patients with Multiple Myeloma
HSMN NewsFeed - 15 Oct 2007
Clinical Studies Show REMICADE Reduces Incidence of Bowel Surgeries in Ulcerative Colitis Patients
Clinical Studies Show REMICADE Reduces Incidence of Bowel Surgeries in Ulcerative Colitis Patients
HSMN NewsFeed - 15 Oct 2007
UPDATE: FDA Approves ISENTRESS(TM) (raltegravir) Tablets, First-in-Class Oral HIV-1 Integrase Inhibitor
UPDATE: FDA Approves ISENTRESS(TM) (raltegravir) Tablets, First-in-Class Oral HIV-1 Integrase Inhibitor
HSMN NewsFeed - 15 Oct 2007
Pipex Pharmaceuticals Appoints David A. Newsome, M.D. as Chief Scientific Officer
Pipex Pharmaceuticals Appoints David A. Newsome, M.D. as Chief Scientific Officer
HSMN NewsFeed - 15 Oct 2007
Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb
Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb
HSMN NewsFeed - 15 Oct 2007
Sepracor Announces Senior Management Appointments as Part of Commercial Re-Organization
Sepracor Announces Senior Management Appointments as Part of Commercial Re-Organization
HSMN NewsFeed - 15 Oct 2007
Covidien and BioSynthema Sign Exclusive Agreements for Cancer Therapy Technology
Covidien and BioSynthema Sign Exclusive Agreements for Cancer Therapy Technology
HSMN NewsFeed - 15 Oct 2007
Pfizer Engages with Nation's Physicians Through Sermo to Improve Patient Care
Pfizer Engages with Nation's Physicians Through Sermo to Improve Patient Care
HSMN NewsFeed - 12 Oct 2007
Anesthesia Drugs Market to Grow to $4.3 Billion by 2011 as Populations and Uses for Anesthesia Increase
Anesthesia Drugs Market to Grow to $4.3 Billion by 2011 as Populations and Uses for Anesthesia Increase
HSMN NewsFeed - 12 Oct 2007
Alpharma Closes Transaction to License U.S. Rights for Prescription Topical NSAID Pain Drug
Alpharma Closes Transaction to License U.S. Rights for Prescription Topical NSAID Pain Drug
HSMN NewsFeed - 12 Oct 2007
Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
HSMN NewsFeed - 11 Oct 2007
McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products
McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products
HSMN NewsFeed - 11 Oct 2007
AkaRx and MGI PHARMA Announce Closing of Development and License Agreement
AkaRx and MGI PHARMA Announce Closing of Development and License Agreement
HSMN NewsFeed - 11 Oct 2007
Akorn, Inc. Signs an Exclusive Licensing, Development and Supply Agreement with Sofgen Pharmaceuticals
Akorn, Inc. Signs an Exclusive Licensing, Development and Supply Agreement with Sofgen Pharmaceuticals
HSMN NewsFeed - 11 Oct 2007
Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
HSMN NewsFeed - 10 Oct 2007
Lannett Company Comments on Recent FDA Announcement for Levothyroxine Sodium
Lannett Company Comments on Recent FDA Announcement for Levothyroxine Sodium
HSMN NewsFeed - 10 Oct 2007
Accera, Inc. Names William T. Poncy Vice President of Commercial Development
Accera, Inc. Names William T. Poncy Vice President of Commercial Development
HSMN NewsFeed - 10 Oct 2007
NuPathe Inc. Names Jerry McLaughlin as Vice President of Commercial Operations
NuPathe Inc. Names Jerry McLaughlin as Vice President of Commercial Operations
HSMN NewsFeed - 10 Oct 2007
ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
HSMN NewsFeed - 9 Oct 2007
Emergent BioSolutions Announces the Appointment of Denise Landry as Senior Vice President, Quality
Emergent BioSolutions Announces the Appointment of Denise Landry as Senior Vice President, Quality
HSMN NewsFeed - 9 Oct 2007
orBec(R) Clinical Summary Published in "Expert Opinion on Investigational Drugs"
orBec(R) Clinical Summary Published in "Expert Opinion on Investigational Drugs"
HSMN NewsFeed - 8 Oct 2007
NPS Pharmaceuticals Names Brian O'Callaghan as New Chief Commercial Officer
NPS Pharmaceuticals Names Brian O'Callaghan as New Chief Commercial Officer
HSMN NewsFeed - 8 Oct 2007
Cyclacel Pharmaceuticals Acquires Specialty Pharmaceutical Business Focused on the Oncology Market
Cyclacel Pharmaceuticals Acquires Specialty Pharmaceutical Business Focused on the Oncology Market
HSMN NewsFeed - 8 Oct 2007
21st World Congress of Dermatology Highlights Clinical Significance of Photodynamic Therapy
21st World Congress of Dermatology Highlights Clinical Significance of Photodynamic Therapy
HSMN NewsFeed - 5 Oct 2007
Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
HSMN NewsFeed - 5 Oct 2007
POZEN Plans to Submit Response to Approvable Letter For Trexima(TM) Within the Next Ten Days
POZEN Plans to Submit Response to Approvable Letter For Trexima(TM) Within the Next Ten Days
HSMN NewsFeed - 4 Oct 2007
Shire's ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
Shire's ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
HSMN NewsFeed - 4 Oct 2007
Declan P. Doogan, M.D. Joins IRX Therapeutics as Advisor on Global Product Development
Declan P. Doogan, M.D. Joins IRX Therapeutics as Advisor on Global Product Development
HSMN NewsFeed - 4 Oct 2007
Urigen Pharmaceuticals, Inc. Appoints Dennis H. Giesing, PhD as Chief Scientific Officer
Urigen Pharmaceuticals, Inc. Appoints Dennis H. Giesing, PhD as Chief Scientific Officer
HSMN NewsFeed - 4 Oct 2007
Dr. Martin Mackay Named President of Pfizer Global Research and Development
Dr. Martin Mackay Named President of Pfizer Global Research and Development
HSMN NewsFeed - 4 Oct 2007
Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc.
Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc.
HSMN NewsFeed - 4 Oct 2007
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
HSMN NewsFeed - 3 Oct 2007
Bioject Announces Roche and Trimeris Update on the Use of Fuzeon(R) with Biojector(R) 2000
Bioject Announces Roche and Trimeris Update on the Use of Fuzeon(R) with Biojector(R) 2000
HSMN NewsFeed - 3 Oct 2007
Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
HSMN NewsFeed - 3 Oct 2007
Prism Pharmaceuticals Appoints Maurits Geerlings Vice President of Business Development
Prism Pharmaceuticals Appoints Maurits Geerlings Vice President of Business Development
HSMN NewsFeed - 3 Oct 2007
Pediatric Asthma Programs With CyDex Captisol Technology Acquired by AstraZeneca
Pediatric Asthma Programs With CyDex Captisol Technology Acquired by AstraZeneca
HSMN NewsFeed - 3 Oct 2007
Callisto Pharmaceuticals Announces Major Strategic Initiative for Guanilib in GI Disorders
Callisto Pharmaceuticals Announces Major Strategic Initiative for Guanilib in GI Disorders
HSMN NewsFeed - 3 Oct 2007
ImmunoGen, Inc. Hires Craig Barrows as Vice President, General Counsel and Secretary
ImmunoGen, Inc. Hires Craig Barrows as Vice President, General Counsel and Secretary
HSMN NewsFeed - 3 Oct 2007
Cheryl Fossum Graham Joins Knopp Neurosciences as Head of Regulatory and Development Strategy
Cheryl Fossum Graham Joins Knopp Neurosciences as Head of Regulatory and Development Strategy
HSMN NewsFeed - 2 Oct 2007
Mylan Appoints Rajiv Malik as Executive Vice President, Head of Global Technical Operations
Mylan Appoints Rajiv Malik as Executive Vice President, Head of Global Technical Operations
HSMN NewsFeed - 2 Oct 2007
Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa
Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa
HSMN NewsFeed - 2 Oct 2007
Mylan Announces Appointment of Harry A. Korman as President, North America
Mylan Announces Appointment of Harry A. Korman as President, North America
HSMN NewsFeed - 2 Oct 2007
Othera Pharmaceuticals Appoints Dr. Frederick R. Rickles Chief Scientific Officer
Othera Pharmaceuticals Appoints Dr. Frederick R. Rickles Chief Scientific Officer
HSMN NewsFeed - 2 Oct 2007
Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
HSMN NewsFeed - 2 Oct 2007
ARIAD Names Vice President, Clinical Operations to Further Enhance Global Clinical Development Efforts
ARIAD Names Vice President, Clinical Operations to Further Enhance Global Clinical Development Efforts
HSMN NewsFeed - 2 Oct 2007
Isis Announces HSR Approval and Closure of Its Collaboration With Ortho-McNeil, Inc.
Isis Announces HSR Approval and Closure of Its Collaboration With Ortho-McNeil, Inc.
HSMN NewsFeed - 1 Oct 2007
Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
HSMN NewsFeed - 1 Oct 2007
Valeant Pharmaceuticals to Partner with ASCEND Therapeutics to Promote Migranal(R) to OB/GYNs
Valeant Pharmaceuticals to Partner with ASCEND Therapeutics to Promote Migranal(R) to OB/GYNs
HSMN NewsFeed - 1 Oct 2007
Mylan Announces Appointment of Gregory L. (Greg) Sheldon as Global Chief Information Officer
Mylan Announces Appointment of Gregory L. (Greg) Sheldon as Global Chief Information Officer
HSMN NewsFeed - 1 Oct 2007
Warner Chilcott Files Lawsuit Against Watson Laboratories, Inc. for Infringement of FEMCON FE Patent
Warner Chilcott Files Lawsuit Against Watson Laboratories, Inc. for Infringement of FEMCON FE Patent
HSMN NewsFeed - 1 Oct 2007
Theratechnologies Reports Positive 52-Week Phase 3 Results for its Lead Drug Candidate Tesamorelin
Theratechnologies Reports Positive 52-Week Phase 3 Results for its Lead Drug Candidate Tesamorelin
HSMN NewsFeed - 1 Oct 2007
Recordati Acquires Orphan Europe, a European Group Specialized in Rare Diseases
Recordati Acquires Orphan Europe, a European Group Specialized in Rare Diseases
HSMN NewsFeed - 28 Sep 2007
Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
HSMN NewsFeed - 28 Sep 2007
Jack Anthony to Resign From VaxGen's Board After Accepting CEO Position at Osprey Pharmaceuticals
Jack Anthony to Resign From VaxGen's Board After Accepting CEO Position at Osprey Pharmaceuticals
HSMN NewsFeed - 27 Sep 2007
Adams Respiratory Therapeutics Files Lawsuit Against Perrigo for Infringement of Mucinex(R) Patent
Adams Respiratory Therapeutics Files Lawsuit Against Perrigo for Infringement of Mucinex(R) Patent
HSMN NewsFeed - 27 Sep 2007
Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
HSMN NewsFeed - 27 Sep 2007
FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
HSMN NewsFeed - 27 Sep 2007
Amgen Receives Proposal for Amending EU Prescribing Information for Aranesp(R)
Amgen Receives Proposal for Amending EU Prescribing Information for Aranesp(R)
HSMN NewsFeed - 27 Sep 2007
Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share
Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share
HSMN NewsFeed - 27 Sep 2007
NeurogesX' NGX-4010 MAA Filed and Accepted for Review by EMEA for Treatment of Peripheral Neuropathic Pain
NeurogesX' NGX-4010 MAA Filed and Accepted for Review by EMEA for Treatment of Peripheral Neuropathic Pain
HSMN NewsFeed - 27 Sep 2007
BrainCells Inc., Taisho Pharmaceutical Co., Ltd. Sign Licensing Agreement for Novel CNS Program
BrainCells Inc., Taisho Pharmaceutical Co., Ltd. Sign Licensing Agreement for Novel CNS Program
HSMN NewsFeed - 27 Sep 2007
Critical Therapeutics and Dey Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets
Critical Therapeutics and Dey Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets
HSMN NewsFeed - 27 Sep 2007
Asphelia Pharmaceuticals Appoints Francois-Xavier Frapaise As President and Chief Executive Officer
Asphelia Pharmaceuticals Appoints Francois-Xavier Frapaise As President and Chief Executive Officer
HSMN NewsFeed - 26 Sep 2007
Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
HSMN NewsFeed - 26 Sep 2007
Titan Adds Dr. Marc Rubin to Executive Management Team as President and Chief Executive Officer
Titan Adds Dr. Marc Rubin to Executive Management Team as President and Chief Executive Officer
HSMN NewsFeed - 25 Sep 2007
Critical Therapeutics Highlights Near-Term Milestones to Drive Commercial Success and Clinical Development
Critical Therapeutics Highlights Near-Term Milestones to Drive Commercial Success and Clinical Development
HSMN NewsFeed - 25 Sep 2007
Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
HSMN NewsFeed - 25 Sep 2007
Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
HSMN NewsFeed - 25 Sep 2007
TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimer's Disease
TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimer's Disease
HSMN NewsFeed - 25 Sep 2007
ULURU Inc. Announces the Appointment of Renaat Van den Hooff to Join Executive Team
ULURU Inc. Announces the Appointment of Renaat Van den Hooff to Join Executive Team
HSMN NewsFeed - 25 Sep 2007
Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
HSMN NewsFeed - 25 Sep 2007
Depomed and Watson Expand ProQuin(R) XR Promotion Agreement to Include Ob/Gyn Field
Depomed and Watson Expand ProQuin(R) XR Promotion Agreement to Include Ob/Gyn Field
HSMN NewsFeed - 24 Sep 2007
Labopharm provides update on U.S. regulatory process for once-daily Tramadol
Labopharm provides update on U.S. regulatory process for once-daily Tramadol
HSMN NewsFeed - 24 Sep 2007
Warner Chilcott Files Lawsuit Against Barr Laboratories, Inc. for Infringement of FEMCON FE Patent
Warner Chilcott Files Lawsuit Against Barr Laboratories, Inc. for Infringement of FEMCON FE Patent
HSMN NewsFeed - 24 Sep 2007
Acceleron Pharma Appoints Niels Borgstein, M.D. as Vice President, Medical Research
Acceleron Pharma Appoints Niels Borgstein, M.D. as Vice President, Medical Research
HSMN NewsFeed - 24 Sep 2007
Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
HSMN NewsFeed - 24 Sep 2007
US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer
US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer
HSMN NewsFeed - 24 Sep 2007
GenomeQuest, Inc. Announces $4 Million in New Venture Funding to Bolster Enterprise Offering
GenomeQuest, Inc. Announces $4 Million in New Venture Funding to Bolster Enterprise Offering
HSMN NewsFeed - 24 Sep 2007
Dyadic Announces Termination of Employment of its President and CEO, Mark A. Emalfarb
Dyadic Announces Termination of Employment of its President and CEO, Mark A. Emalfarb
HSMN NewsFeed - 24 Sep 2007
Phase 3 Pivotal Trial of TOCOSOL(R) Paclitaxel Does Not Meet Primary Endpoint
Phase 3 Pivotal Trial of TOCOSOL(R) Paclitaxel Does Not Meet Primary Endpoint
HSMN NewsFeed - 24 Sep 2007
ARIAD Initiates Phase 3 'Succeed' Trial of Oral Deforolimus in Patients with Metastatic Sarcomas
ARIAD Initiates Phase 3 'Succeed' Trial of Oral Deforolimus in Patients with Metastatic Sarcomas
HSMN NewsFeed - 24 Sep 2007
Pro-Pharmaceuticals Names Theodore Zucconi, Ph.D., President; Nominated to the Board of Directors
Pro-Pharmaceuticals Names Theodore Zucconi, Ph.D., President; Nominated to the Board of Directors
HSMN NewsFeed - 24 Sep 2007
Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
HSMN NewsFeed - 21 Sep 2007
Vectibix(TM) (panitumumab) Receives Positive Opinion for Marketing Authorization in the European Union
Vectibix(TM) (panitumumab) Receives Positive Opinion for Marketing Authorization in the European Union
HSMN NewsFeed - 21 Sep 2007
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
HSMN NewsFeed - 21 Sep 2007
Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
HSMN NewsFeed - 21 Sep 2007
Pipex Pharmaceuticals Plans November NDA Filing for COPREXA Based on Pre-NDA Meetings With FDA
Pipex Pharmaceuticals Plans November NDA Filing for COPREXA Based on Pre-NDA Meetings With FDA
HSMN NewsFeed - 20 Sep 2007
Robert S. Fishman, MD, FCCP Joins Alexza as Vice President, Medical Affairs
Robert S. Fishman, MD, FCCP Joins Alexza as Vice President, Medical Affairs
HSMN NewsFeed - 20 Sep 2007
European Committee Issues Positive Opinion on Wyeth's TORISEL(TM) for Advanced Renal Cell Carcinoma
European Committee Issues Positive Opinion on Wyeth's TORISEL(TM) for Advanced Renal Cell Carcinoma
HSMN NewsFeed - 20 Sep 2007
FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
HSMN NewsFeed - 20 Sep 2007
Medicure Announces Completion of Enrollment in Pivotal Phase 3 MEND-CABG II Trial
Medicure Announces Completion of Enrollment in Pivotal Phase 3 MEND-CABG II Trial
HSMN NewsFeed - 20 Sep 2007
CG Therapeutics Appoints Dr. Christopher S. Henney as Chairman of Board of Directors
CG Therapeutics Appoints Dr. Christopher S. Henney as Chairman of Board of Directors
HSMN NewsFeed - 20 Sep 2007
ImaRx Therapeutics Names Richard L. Love as Chairman and Announces Management Appointments
ImaRx Therapeutics Names Richard L. Love as Chairman and Announces Management Appointments
HSMN NewsFeed - 20 Sep 2007
ImClone Systems Expands IMC-A12 Development with Ten New Planned Clinical Trials
ImClone Systems Expands IMC-A12 Development with Ten New Planned Clinical Trials
HSMN NewsFeed - 20 Sep 2007
Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
HSMN NewsFeed - 19 Sep 2007
Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
HSMN NewsFeed - 19 Sep 2007
PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
HSMN NewsFeed - 19 Sep 2007
Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Maintains Full Immunogenicity at 50 Weeks in Phase 3 Trial
Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Maintains Full Immunogenicity at 50 Weeks in Phase 3 Trial
HSMN NewsFeed - 19 Sep 2007
FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
HSMN NewsFeed - 19 Sep 2007
Novelos Therapeutics Elects Dr. Stephen Hill to Serve as Chairman of Board of Directors
Novelos Therapeutics Elects Dr. Stephen Hill to Serve as Chairman of Board of Directors
HSMN NewsFeed - 19 Sep 2007
Adams Respiratory Therapeutics and Lipocine Enter into License and Collaboration Agreement
Adams Respiratory Therapeutics and Lipocine Enter into License and Collaboration Agreement
HSMN NewsFeed - 19 Sep 2007
Alnylam Announces the Termination of its Collaboration with Merck & Co., Inc.
Alnylam Announces the Termination of its Collaboration with Merck & Co., Inc.
HSMN NewsFeed - 19 Sep 2007
Pharmacyclics Announces Addition of Robert W. Duggan to Board of Directors
Pharmacyclics Announces Addition of Robert W. Duggan to Board of Directors
HSMN NewsFeed - 19 Sep 2007
CuraGen Corporation Announces Appointment of Dr. Timothy M. Shannon as President and Chief Executive Officer
CuraGen Corporation Announces Appointment of Dr. Timothy M. Shannon as President and Chief Executive Officer
HSMN NewsFeed - 18 Sep 2007
Anika Therapeutics Promotes Randall Wilhoite to Vice President-Operations
Anika Therapeutics Promotes Randall Wilhoite to Vice President-Operations
HSMN NewsFeed - 18 Sep 2007
New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
HSMN NewsFeed - 18 Sep 2007
Long-Term Data Reinforce Safety and Efficacy Profile of Pfizer's New HIV Drug Selzentry(TM) (Maraviroc)
Long-Term Data Reinforce Safety and Efficacy Profile of Pfizer's New HIV Drug Selzentry(TM) (Maraviroc)
HSMN NewsFeed - 18 Sep 2007
New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
HSMN NewsFeed - 18 Sep 2007
Presidio Pharmaceuticals Adds Industry Veteran Dr. Richard Colonno as Chief Scientific Officer
Presidio Pharmaceuticals Adds Industry Veteran Dr. Richard Colonno as Chief Scientific Officer
HSMN NewsFeed - 18 Sep 2007
Nile Therapeutics, Inc. Completes $20 Million Financing and Reverse Merger with SMI Products, Inc.
Nile Therapeutics, Inc. Completes $20 Million Financing and Reverse Merger with SMI Products, Inc.
HSMN NewsFeed - 18 Sep 2007
Acceleron Pharma Appoints John L. Knopf, Ph.D., as Chief Executive Officer
Acceleron Pharma Appoints John L. Knopf, Ph.D., as Chief Executive Officer
HSMN NewsFeed - 18 Sep 2007
OSI Pharmaceuticals Announces Patent Term Extension for Tarceva(R) (erlotinib)
OSI Pharmaceuticals Announces Patent Term Extension for Tarceva(R) (erlotinib)
HSMN NewsFeed - 18 Sep 2007
New Data Support Long-Term Efficacy and Safety in Patients Who Took Exubera for Eight Years
New Data Support Long-Term Efficacy and Safety in Patients Who Took Exubera for Eight Years
HSMN NewsFeed - 18 Sep 2007
Sosei Announces Completion of Phase II Trial of AD 337 in Fibromyalgia Syndrome
Sosei Announces Completion of Phase II Trial of AD 337 in Fibromyalgia Syndrome
HSMN NewsFeed - 17 Sep 2007
Former FDA Official John Taylor III to Join BIO as Executive Vice President of Health
Former FDA Official John Taylor III to Join BIO as Executive Vice President of Health
HSMN NewsFeed - 17 Sep 2007
Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
HSMN NewsFeed - 17 Sep 2007
Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
HSMN NewsFeed - 17 Sep 2007
Paladin and Labopharm Launch Tridural(TM) Once-Daily Tramadol Product in Canada
Paladin and Labopharm Launch Tridural(TM) Once-Daily Tramadol Product in Canada
